Richard B. Markham

Dr. Richard B. Markham is a professor of molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health and holds a joint appointment in medicine at the Johns Hopkins University School of Medicine. His research uses different model systems to study the pathogenesis and prevention of infectious diseases such as HIV, malaria and tuberculosis. Recent work has focused on the development of a novel vaccine platform to address these public health problems. As Chair of the School of Public Health’s Technology Transfer Committee, Dr. Markham is also engaged in efforts by the school to translate innovative technologies into wider clinical application. Among Dr. Markham’s many professional honors, he holds a patent on a candidate malaria vaccine and co-holds a patent related to preventing the transepithelial transmission of HIV. He is a fellow of the Infectious Disease Society of America. Dr. Markham earned his M.D. from the Albert Einstein College of Medicine and pursued research and clinical infectious disease fellowships at the National Institute of Allergy and Infectious Diseases and Harvard Medical School. He serves on the faculty of the Johns Hopkins Vaccine Initiative.